Influenza B viruses (IBVs) circulate annually along with influenza A (IAV) strains during seasonal
epidemics. IBV can dominate influenza seasons and cause severe disease, particularly …

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …

To the Editor—We report the kinetics of immune responses in relation to clinical and virological
features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) that …

An improved understanding of human T cell-mediated immunity in COVID-19 is important
for optimizing therapeutic and vaccine strategies. Experience with influenza shows that …

Persistent and durable immunological memory forms the basis of any successful vaccination
protocol. Generation of pre-existing memory B cell and T cell pools is thus the key for …

To better understand primary and recall T cell responses during coronavirus disease 2019 (COVID-19),
it is important to examine unmanipulated severe acute respiratory syndrome …

Influenza is a major global health problem, causing infections of the respiratory tract, often
leading to acute pneumonia, life-threatening complications and even deaths. Over the last …

T cells are defined by a heterodimeric surface receptor, the T cell receptor (TCR), that mediates
recognition of pathogen-associated epitopes through interactions with peptide and major …

SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4 + T cell
responses. It is not yet clear whether vaccine-induced follicular helper CD4 + T (T FH ) cell …

The human lung harbors a large population of resident memory T cells (Trm cells). These cells
are perfectly positioned to mediate rapid protection against respiratory pathogens such as …